Moreover, it has been reported that CTLA-4 inhibition favours the expansion of PD-1-expressing tumour-infiltrating lymphocytes, whereas the inhibition of PD-1 leads to the upregulation of CTLA-4 in these cells. This evidence concerns the gene CTLA4 and neoplasm.